Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 246

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells

Open access
Blat, Dan, Zigmond, Ehud, Alteber, Zoya, Waks, Tova, Eshhar, Zelig · 2014 · Molecular Therapy

Abstract

The adoptive transfer of regulatory T cells (Tregs) offers a promising strategy to combat pathologies that are characterized by aberrant immune activation, including graft rejection and autoinflammatory diseases. Expression of a chimeric antigen receptor (CAR) gene in Tregs redirects them to the site of autoimmune activity, thereby increasing their suppressive efficiency while avoiding systemic immunosuppression. Since carcinoembryonic antigen (CEA) has been shown to be overexpressed in both human colitis and colorectal cancer, we treated CEA-transgenic mice that were induced to develop colitis with CEA-specific CAR Tregs. Two disease models were employed: T-cell-transfer colitis as well as the azoxymethane-dextran sodium sulfate model for colitis-associated colorectal cancer. Systemically administered CEA-specific (but not control) CAR Tregs accumulated in the colons of diseased mice. In both model systems, CEA-specific CAR Tregs suppressed the severity of colitis compared to control Tregs. Moreover, in the azoxymethane-dextran sodium sulfate model, CEA-specific CAR Tregs significantly decreased the subsequent colorectal tumor burden. Our data demonstrate that CEA-specific CAR Tregs exhibit a promising potential in ameliorating ulcerative colitis and in hindering colorectal cancer development. Collectively, this study provides a proof of concept for the therapeutic potential of CAR Tregs in colitis patients as well as in other autoimmune inflammatory disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mt.2014.41

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 44

  1. Loftus, 2004, Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences, Gastroenterology, 126, 1504, 10.1053/j.gastro.2004.01.063 · DOI · Paper page
  2. Eaden, 2001, The risk of colorectal cancer in ulcerative colitis: a meta-analysis, Gut, 48, 526, 10.1136/gut.48.4.526 · DOI · Paper page
  3. Seibold, 1998, pANCA represents a cross-reactivity to enteric bacterial antigens, J Clin Immunol, 18, 153, 10.1023/A:1023203118100 · DOI
  4. Ohkura, 2013, Development and maintenance of regulatory T cells, Immunity, 38, 414, 10.1016/j.immuni.2013.03.002 · DOI · Paper page
  5. Izcue, 2009, Regulatory lymphocytes and intestinal inflammation, Annu Rev Immunol, 27, 313, 10.1146/annurev.immunol.021908.132657 · DOI · Paper page
  6. Ochs, 2007, IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity, Immunol Res, 38, 112, 10.1007/s12026-007-0022-2 · DOI · Paper page
  7. Collison, 2007, The inhibitory cytokine IL-35 contributes to regulatory T-cell function, Nature, 450, 566, 10.1038/nature06306 · DOI · Paper page
  8. Tarbell, 2007, Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice, J Exp Med, 204, 191, 10.1084/jem.20061631 · DOI · Paper page
  9. Stephens, 2009, Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg, Eur J Immunol, 39, 1108, 10.1002/eji.200839073 · DOI · Paper page
  10. Wright, 2009, Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis, Proc Natl Acad Sci USA, 106, 19078, 10.1073/pnas.0907396106 · DOI · Paper page
  11. Elinav, 2008, Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice, Gastroenterology, 134, 2014, 10.1053/j.gastro.2008.02.060 · DOI · Paper page
  12. Elinav, 2009, Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor, Gastroenterology, 136, 1721, 10.1053/j.gastro.2009.01.049 · DOI · Paper page
  13. Gross, 1989, Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity, Proc Natl Acad Sci USA, 86, 10024, 10.1073/pnas.86.24.10024 · DOI · Paper page
  14. Kochenderfer, 2012, B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells, Blood, 119, 2709, 10.1182/blood-2011-10-384388 · DOI · Paper page
  15. Louis, 2011, Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma, Blood, 118, 6050, 10.1182/blood-2011-05-354449 · DOI · Paper page
  16. Smithson, 1996, Heterogeneous expression of carcinoembryonic antigen in the normal colon and upregulation in active ulcerative colitis, J Pathol, 180, 146, 10.1002/(SICI)1096-9896(199610)180:2<146::AID-PATH643>3.0.CO;2-E · doi:10.1002/(sici)1096-9896(199610)180:2<146::aid-path643>3.0.co;2-e
  17. Chmielewski, 2012, T cells that target carcinoembryonic antigen eradicate orthotopic pancreatic carcinomas without inducing autoimmune colitis in mice, Gastroenterology, 143, 1095, 10.1053/j.gastro.2012.06.037 · DOI
  18. Chan, 2004, Novel mouse model for carcinoembryonic antigen-based therapy, Mol Ther, 9, 775, 10.1016/j.ymthe.2004.03.009 · DOI
  19. Tanaka, 2003, A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate, Cancer Sci, 94, 965, 10.1111/j.1349-7006.2003.tb01386.x · DOI · Paper page
  20. Berg, 1996, Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses, J Clin Invest, 98, 1010, 10.1172/JCI118861 · DOI · Paper page
  21. Liu, 2003, CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4, J Immunol, 171, 5012, 10.4049/jimmunol.171.10.5012 · DOI · Paper page
  22. Singh, 2001, Control of intestinal inflammation by regulatory T cells, Immunol Rev, 182, 190, 10.1034/j.1600-065X.2001.1820115.x · DOI · Paper page
  23. Parkhurst, 2011, T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis, Mol Ther, 19, 620, 10.1038/mt.2010.272 · DOI · Paper page
  24. Zhao, 2009, A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity, J Immunol, 183, 5563, 10.4049/jimmunol.0900447 · DOI · Paper page
  25. Dieleman, 1998, Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines, Clin Exp Immunol, 114, 385, 10.1046/j.1365-2249.1998.00728.x · DOI · Paper page
  26. Dieleman, 1994, Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice, Gastroenterology, 107, 1643, 10.1016/0016-5085(94)90803-6 · DOI · Paper page
  27. Maloy, 2005, Cure of innate intestinal immune pathology by CD4+CD25+ regulatory T cells, Immunol Lett, 97, 189, 10.1016/j.imlet.2005.01.004 · DOI
  28. Gallimore, 2008, Regulatory T cells and tumour immunity - observations in mice and men, Immunology, 123, 157, 10.1111/j.1365-2567.2007.02748.x · DOI
  29. Erdman, 2003, CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice, Am J Pathol, 162, 691, 10.1016/S0002-9440(10)63863-1 · DOI · Paper page
  30. Fearon, 1990, A genetic model for colorectal tumorigenesis, Cell, 61, 759, 10.1016/0092-8674(90)90186-I · DOI · Paper page
  31. Lim, 2005, Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells, J Immunol, 175, 4180, 10.4049/jimmunol.175.7.4180 · DOI · Paper page
  32. Fallarino, 2003, Modulation of tryptophan catabolism by regulatory T cells, Nat Immunol, 4, 1206, 10.1038/ni1003 · DOI · Paper page
  33. Tiemessen, 2007, CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages, Proc Natl Acad Sci USA, 104, 19446, 10.1073/pnas.0706832104 · DOI · Paper page
  34. Thornton, 2000, Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific, J Immunol, 164, 183, 10.4049/jimmunol.164.1.183 · DOI · Paper page
  35. Andersson, 2008, CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner, J Exp Med, 205, 1975, 10.1084/jem.20080308 · DOI · Paper page
  36. Nadig, 2010, In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells, Nat Med, 16, 809, 10.1038/nm.2154 · DOI · Paper page
  37. Tang, 2006, Regulatory T-cell physiology and application to treat autoimmunity, Immunol Rev, 212, 217, 10.1111/j.0105-2896.2006.00421.x · DOI · Paper page
  38. Friedmann-Morvinski, 2005, Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation, Blood, 105, 3087, 10.1182/blood-2004-09-3737 · DOI
  39. Pulè, 2005, A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells, Mol Ther, 12, 933, 10.1016/j.ymthe.2005.04.016 · DOI · Paper page
  40. Xu, 2007, Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta, J Immunol, 178, 6725, 10.4049/jimmunol.178.11.6725 · DOI · Paper page
  41. Zhou, 2010, Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu, J Immunol, 185, 2675, 10.4049/jimmunol.1000598 · DOI · Paper page
  42. Beavis, 2011, Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cells, Proc Natl Acad Sci USA, 108, 16717, 10.1073/pnas.1112722108 · DOI
  43. Parish, 2009, Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation, Curr Protoc Immunol, Chapter 4, Unit4.9
  44. Becker, 2005, In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy, Gut, 54, 950, 10.1136/gut.2004.061283 · DOI · Paper page

Cited by

See all 246

Metadata

Authors
Blat, D., Zigmond, E., Alteber, Z., Waks, T., & Eshhar, Z.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2014-05
Volume
22
Issue
5
Pages
1018-1028
ISSN
1525-0016 (ISSN-L)
OpenAlex
W2067270731
Cited by
246
References
6
FWCI
5.58
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells. https://app.cochat.ai/papers/10.1038/mt.2014.41
The paper
Blat, D., Zigmond, E., Alteber, Z., Waks, T., & Eshhar, Z. (2014). Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells. Molecular Therapy. https://doi.org/10.1038/mt.2014.41

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.